How to cite item

EGFR L718Q mutation occurs without T790M mutation in a lung adenocarcinoma patient with acquired resistance to osimertinib

   
@article{ATM25283,
	author = {Lei Ma and Rui Chen and Fang Wang and Li-Li Ma and Ming-Ming Yuan and Rong-Rong Chen and Jiang Liu},
	title = { EGFR  L718Q mutation occurs without T790M mutation in a lung adenocarcinoma patient with acquired resistance to osimertinib},
	journal = {Annals of Translational Medicine},
	volume = {7},
	number = {9},
	year = {2019},
	keywords = {},
	abstract = {Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) improve the clinical outcomes of EGFR-mutant non-small cell lung cancer (NSCLC) patients significantly, however, acquired resistance occurs almost inevitably. The underlying mechanisms of osimertinib resistance and treatment strategies after resistance remain largely unknown. Here we reported a case of lung adenocarcinoma patient who progressed on osimertinib with EGFR L718Q mutation in the absence of T790M mutation. The patient received icotinib as an exploratory treatment regimen for a short while with stable disease observed. Unfortunately, the therapy was discontinued due to intolerable hepatotoxicity. This is the first clinical report of the use of the effective EGFR-TKI treatment after L718Q-induced osimertinib resistance. The therapeutic regimens for NSCLC patients progressed on osimertinib still require large-scale investigation.},
	issn = {2305-5847},	url = {https://atm.amegroups.org/article/view/25283}
}